Madeleine Armstrong
@ByMadeleineA
Followers
8K
Following
5K
Statuses
16K
Senior reporter at @ApexOnco; cat lover; Croydon Harrier
London, England
Joined May 2008
RT @JacobPlieth: How many lives does $XLO have left? First $GILD, now $ABBV comes with a bailout worth more up front than company's entire…
0
2
0
$GILD Car-T sales flattening in Q4 2024. Company blames Car-T competition, but also "slower-than-targeted uptake of cell therapy as a class"
1
0
0
RT @JacobPlieth: $XLO just did it again! Had cash only to mid-2025, now gets $10m in equity + $42m cash up front from $ABBV
0
2
0
@mopgcw @avidresearch It's to do with mevrometostat data? I'm not sure, @JacobPlieth's been looking at this one
1
0
1
We've now got a PDUA date for linvoseltamab: 10 July $REGN
0
1
4
RT @JacobPlieth: So who broke the $PFE mevrometostat embargo? Originally a #GU25 late-breaker not due to be revealed until Thu. Abstract un…
0
2
0
$PFE looks towards more bladder cancer uses, after reporting long-term data with Padcev at #GU25 $MRK $AZN $JNJ $CGON
0
0
3
RT @adar170: $SWTX Merck KGaA In Advanced Discussions To Acquire SpringWorks Therapeutics, Sources Say reuters
0
15
0
@ApexOnco Also looks like there's been a delay to $INCY's phase 3 trial of its BET inhibitor INCB057643; now to start 2025, from H2 2024 previously
0
0
0
Orca heads to the FDA. @JacobPlieth's take on whether Orca-T can succeed where the likes of Molmed, Kiadis & Bellicum failed, via @ApexOnco
0
4
5
RT @JacobPlieth: Say a Hail Mary for $GSK's phase 3 Costar Lung study of cobolimab. Via @ApexOnco -> $AZN https://t…
0
2
0
$KURA's Komet fizzles - shares down 13% on the Komet-001 "win". $SNDX up 10%!
0
1
5